Hepatitis Monthly

Published by: Kowsar

Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains

Katayoun Samimi-Rad 1 , * , Freshteh Asgari 2 , Mohsen Nasiritoosi 3 , Abdoulreza Esteghamati 4 , Azar Azarkeyvan 5 , Seyedeh Masoomeh Eslami 6 , Farhad Zamani 7 , Lars Magnius 8 , Seyed-Moayed Alavian 8 and Heléne Norder 9
Authors Information
1 Department of Virology, School of Public Health, Tehran University of Medical Sciences, P. O. Box: 6446, Tehran, IR Iran
2 Center for Disease Control, Deputy of Health, Ministry of Health and Medical Education, Tehran, IR Iran
3 Department of Internal Medicine, Gastroenterology and Hepatology Section, Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Pediatric, Tehran University of Medical Sciences, , Tehran, IR Iran
5 Iranian Blood Transfusion Organization (IBTO), Thalassemia Center,, Tehran, IR Iran
6 Gastrointestinal and Liver Disease Research Center, Firoozgar Hospital, Tehran University of Medical Sciences, , Tehran, IR Iran
7 Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institute, Solna, Sweden
8 Research Center for Gastroenterology and Liver Disease, Baqiatallah University of Medical Sciences, , Tehran, IR Iran
9 Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
Article information
  • Hepatitis Monthly: January 01, 2013, 13 (1); e7699
  • Published Online: January 23, 2013
  • Article Type: Research Article
  • Received: August 12, 2012
  • Revised: November 10, 2012
  • Accepted: November 12, 2012
  • DOI: 10.5812/hepatmon.7699

To Cite: Samimi-Rad K, Asgari F, Nasiritoosi M, Esteghamati A, Azarkeyvan A, et al. Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains, Hepat Mon. 2013 ; 13(1):e7699. doi: 10.5812/hepatmon.7699.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007; 17(6): 425-33[DOI][PubMed]
  • 2. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007; 29(4): 233-8[DOI][PubMed]
  • 3. Alavian S, Tabatabaei S, Lankarani K. Epidemiology of HCV infection among thalassemia patients in eastern Mediterranean countries: a quantitative review of literature. Iranian Red Crescent Medical Journal. 2010; 12(4): 365-76
  • 4. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
  • 5. Samimi-Rad K, Hosseini M, Mobeini G, Asgari F, Alavian SM, Tahaei ME, et al. Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran. East Mediterr Health J. 2012; 18(3): 227-35[PubMed]
  • 6. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006; 9(4): 319-23[PubMed]
  • 7. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, et al. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol. 2001; 65(3): 517-24[DOI][PubMed]
  • 8. Norder H, Bergstrom A, Uhnoo I, Alden J, Weiss L, Czajkowski J, et al. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol. 1998; 36(10): 3066-9[PubMed]
  • 9. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007; 13(2): 156-63[DOI][PubMed]
  • 10. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004; 74(2): 246-52[DOI][PubMed]
  • 11. Alavian SM, Miri SM, Keshvari M, Elizee PK, Behnava B, Tabatabaei SV, et al. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. 2009; 49(10): 2195-9[DOI][PubMed]
  • 12. Shobokshi OA, Serebour FE, Skakni LI. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. Saudi Med J. 2003; 24 Suppl 2-91[PubMed]
  • 13. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol. 1997; 78: 1341-7[PubMed]
  • 14. Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol. 2001; 82: 693-712[PubMed]
  • 15. Azar KA, Hajibeygi B, Nasiri TM, Amini Kafiabad S, Maghsoudlou M, Shadman AH. Trace Back Of Thalassemic Patients With Positive Hcv Markers To Their Donors In Adult Thalassemia Center. Blood (Khoon). 2010; 7(3): 156-61
  • 16. Krause G, Trepka MJ, Whisenhunt RS, Katz D, Nainan O, Wiersma ST, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol. 2003; 24(2): 122-7[DOI][PubMed]
  • 17. Januszkiewicz-Lewandowska D, Wysocki J, Rembowska J, Pernak M, Lewandowski K, Nowak T, et al. Transmission of HCV infection among long-term hospitalized onco-haematological patients. J Hosp Infect. 2003; 53(2): 120-3[DOI][PubMed]
  • 18. Gonzalez-Candelas F, Guiral S, Carbo R, Valero A, Vanaclocha H, Gonzalez F, et al. Patient-to-patient transmission of hepatitis C virus (HCV) during colonoscopy diagnosis. Virol J. 2010; 7: 217[DOI][PubMed]
  • 19. Dencs A, Hettmann A, Martyin T, Jekkel C, Banyai T, Takacs M. Phylogenetic investigation of nosocomial transmission of hepatitis C virus in an oncology ward. J Med Virol. 2011; 83(3): 428-36[DOI][PubMed]
  • 20. Comstock RD, Mallonee S, Fox JL, Moolenaar RL, Vogt TM, Perz JF, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol. 2004; 25(7): 576-83[DOI][PubMed]
  • 21. Bronowicki JP, Venard V, Botte C, Monhoven N, Gastin I, Chone L, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med. 1997; 337(4): 237-40[DOI][PubMed]
  • 22. Perz JF, Thompson ND, Schaefer MK, Patel PR. US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis. 2010; 14(1): 137-51[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments